Director, Contracts, Legal Services, and Compliance

Executive Director, Duchenne Regulatory Science Consortium

Executive Director, Rare Disease Cures Accelerator-Data and Analytics Platform

Vice President, Clinical Outcome Assessment Program

Executive Director, Patient-Reported Outcome Consortium

Executive Director, Translational Therapeutics Accelerator

Executive Director, Translational Therapeutics Accelerator

Executive Director, Polycystic Kidney Diseases Outcomes Consortium

Executive Director of European Office

Vice President, Rare and Orphan Disease Programs

Chief Executive Officer

Executive Director, Electronic Clinical Outcome (eCOA) Consortium

Executive Director, Predictive Safety Testing Consortium

Executive Director, Transplant Therapeutics Consortium

Chief Technology Officer and Director, Data Collaboration Center

Vice President, Model-Informed Drug Development and Quantitative Medicine

Executive Director, Duchenne Regulatory Science Consortium; Executive Director, Critical Path to Therapeutics for the Ataxias

Executive Director, Rare Disease Clinical Outcome Assessment (COA) Consortium

Managing Director, Europe

Chief Financial Officer

Executive Director, Critical Path for Sickle Cell Disease Consortium

Chief Science Officer; Executive Director of Clinical Pharmacology

Executive Director, CURE Drug Repurposing Collaboratory

Executive Director, International Neonatal Consortium

Executive Director, Critical Path for Alzheimer's Disease Consortium

Executive Director, Critical Path for Parkinson's Consortium

Chief Operating Officer,
President

Executive Director, Data Science

Chairman

Vice Chairman

FDA Advisor

Senior Advisor

 Senior Advisor

FDA Advisor

Special Advisor,
Former President and CEO

Special Advisor,
Former President and CEO

Senior Advisor,
Founder and Former CEO